BRIEF-Abeona Therapeutics gets European regulatory approval for early stage gene therapy clinical study

Thu Aug 4, 2016 7:24am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 4 (Reuters) - Abeona Therapeutics Inc

* Abeona therapeutics announces european regulatory approval for phase 1/2 gene therapy clinical study for patients with sanfilippo syndrome type a (mps iiia) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)